0001209191-22-051980.txt : 20221003
0001209191-22-051980.hdr.sgml : 20221003
20221003194814
ACCESSION NUMBER: 0001209191-22-051980
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220627
FILED AS OF DATE: 20221003
DATE AS OF CHANGE: 20221003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALLEN SIMON
CENTRAL INDEX KEY: 0001606829
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 221289252
MAIL ADDRESS:
STREET 1: C/O AMBRX, INC.
STREET 2: 10975 N. TORREY PINES RD.
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815974
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851170950
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201
CITY: LAKEWAY
STATE: TX
ZIP: 78734
BUSINESS PHONE: 737 203 5270
MAIL ADDRESS:
STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201
CITY: LAKEWAY
STATE: TX
ZIP: 78734
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-27
0
0001815974
Anebulo Pharmaceuticals, Inc.
ANEB
0001606829
ALLEN SIMON
C/O ANEBULO PHARMACEUTICALS, INC.
1415 RANCH ROAD 620 SOUTH, SUITE 201
LAKEWAY
TX
78734
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
7.02
2022-06-27
4
A
0
77457
0.00
A
2027-07-31
Common Stock
77457
77457
D
4,841 shares vest immediately. The remainder of the shares vest ratably in 15 quarterly installments (4,841.06 shares each Quarter) from July 1, 2022 through January 1, 2026. All shares subject to the option will vest immediately upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of the option on June 23, 2022.
/s/ James R. Merchant, Attorney-in-Fact
2022-10-03